CH658455A5 - Peptidderivate, verfahren zu deren herstellung und diese enthaltende arzneimittel. - Google Patents

Peptidderivate, verfahren zu deren herstellung und diese enthaltende arzneimittel. Download PDF

Info

Publication number
CH658455A5
CH658455A5 CH1691/82A CH169182A CH658455A5 CH 658455 A5 CH658455 A5 CH 658455A5 CH 1691/82 A CH1691/82 A CH 1691/82A CH 169182 A CH169182 A CH 169182A CH 658455 A5 CH658455 A5 CH 658455A5
Authority
CH
Switzerland
Prior art keywords
carboxylic acid
tetrahydroisoquinoline
alanyl
carboethoxy
mmol
Prior art date
Application number
CH1691/82A
Other languages
German (de)
English (en)
Inventor
John T Suh
Jeffrey N Barton
John R Regan
Original Assignee
Usv Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Usv Pharma Corp filed Critical Usv Pharma Corp
Publication of CH658455A5 publication Critical patent/CH658455A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/26Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/022Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
    • C07K5/0222Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Cardiology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
CH1691/82A 1981-03-19 1982-03-18 Peptidderivate, verfahren zu deren herstellung und diese enthaltende arzneimittel. CH658455A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US24540781A 1981-03-19 1981-03-19

Publications (1)

Publication Number Publication Date
CH658455A5 true CH658455A5 (de) 1986-11-14

Family

ID=22926526

Family Applications (1)

Application Number Title Priority Date Filing Date
CH1691/82A CH658455A5 (de) 1981-03-19 1982-03-18 Peptidderivate, verfahren zu deren herstellung und diese enthaltende arzneimittel.

Country Status (21)

Country Link
JP (1) JPS57165355A (es)
KR (1) KR890001146B1 (es)
AU (1) AU558451B2 (es)
BE (1) BE892552A (es)
CH (1) CH658455A5 (es)
DE (1) DE3209708A1 (es)
DK (1) DK120982A (es)
ES (3) ES510498A0 (es)
FI (1) FI820974L (es)
FR (1) FR2502149A1 (es)
GB (1) GB2095252B (es)
IE (1) IE53076B1 (es)
IL (1) IL65247A (es)
IN (1) IN156096B (es)
IT (1) IT1150697B (es)
NL (1) NL8201066A (es)
NO (1) NO820903L (es)
NZ (1) NZ200047A (es)
PH (1) PH18657A (es)
SE (1) SE8201654L (es)
ZA (1) ZA821833B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3242599A1 (de) * 1982-11-18 1984-05-24 Dr. Karl Thomae Gmbh, 7950 Biberach Neue benzazepinderivate, ihre herstellung und ihre verwendung als arzneimittel
US4410520A (en) * 1981-11-09 1983-10-18 Ciba-Geigy Corporation 3-Amino-[1]-benzazepin-2-one-1-alkanoic acids
US4555502A (en) * 1982-09-30 1985-11-26 Merck & Co., Inc. Aminoacyl-containing dipeptide derivatives useful as antihypertensives
US4410807A (en) * 1982-03-26 1983-10-18 Kay Industries, Inc. Regulating device for polyphase electrical circuits
US4473575A (en) * 1982-07-19 1984-09-25 Ciba-Geigy Corporation 3-Amino-(1)-benzazepin-2-one-1-alkanoic acids
US4520025A (en) * 1982-07-21 1985-05-28 William H. Rorer, Inc. Bicyclic nitrogen heterocyclic ethers and thioethers, and their pharmaceutical uses
DE3302125A1 (de) * 1983-01-22 1984-07-26 Boehringer Ingelheim KG, 6507 Ingelheim Aminosaeure-derivate, verfahren zu ihrer herstellung und verwendung
FI841052A (fi) * 1983-03-16 1984-09-17 Usv Pharma Corp Foereningar foer behandling av blodtryckssjukdomar.
DE3333454A1 (de) * 1983-09-16 1985-04-11 Hoechst Ag, 6230 Frankfurt Verfahren zur herstellung von n-alkylierten dipeptiden und deren estern
DE3622297A1 (de) * 1986-07-03 1988-01-07 Basf Ag Disazothiophenfarbstoffe
US5246943A (en) * 1992-05-19 1993-09-21 Warner-Lambert Company Substituted 1,2,3,4-tetahydroisoquinolines with angiotensin II receptor antagonist properties
ES2122941B1 (es) * 1997-05-29 1999-07-01 Esteve Quimica Sa Procedimiento para la obtencion de quinapril clorhidrato y solvatos utiles para el aislamiento y purificacion de quinapril clorhidrato.
PT1333026E (pt) 2002-01-30 2007-09-17 Servier Lab ''processo para a preparação de perindopril com elevado grau de pureza e intermediários úteis para a sua síntese''
CA2510773C (en) 2002-12-16 2010-04-13 Lupin Limited Crystalline form of quinapril hydrochloride and process for preparing the same
DE60321233D1 (de) * 2003-02-28 2008-07-03 Servier S A Lab Verfahren zur herstellung von perindopril

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2503155A2 (fr) * 1980-10-02 1982-10-08 Science Union & Cie Nouveaux imino diacides substitues, leurs procedes de preparation et leur emploi comme inhibiteur d'enzyme
EP0278530A3 (de) * 1980-08-30 1989-08-02 Hoechst Aktiengesellschaft Aminosäurederivate, Verfahren zu ihrer Herstellung, diese enthaltende Mittel und deren Verwendung
US4344949A (en) * 1980-10-03 1982-08-17 Warner-Lambert Company Substituted acyl derivatives of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids
GB2086390B (en) * 1980-11-03 1984-06-06 Ciba Geigy Ag 1-carboxy-azaalkanoylindoline-2-carboxylic acids process for their manufacture pharmaceutical preparations containing these compounds and their therapeutic application

Also Published As

Publication number Publication date
FR2502149A1 (fr) 1982-09-24
NO820903L (no) 1982-09-20
ES8404317A1 (es) 1984-05-16
FI820974L (fi) 1982-09-20
NL8201066A (nl) 1982-10-18
ZA821833B (en) 1983-01-26
ES521031A0 (es) 1984-12-01
KR830009065A (ko) 1983-12-17
ES521030A0 (es) 1984-05-16
IE820635L (en) 1982-09-19
GB2095252A (en) 1982-09-29
AU8158482A (en) 1982-09-23
JPS57165355A (en) 1982-10-12
ES8307718A1 (es) 1983-08-01
DE3209708A1 (de) 1982-10-21
IN156096B (es) 1985-05-11
ES510498A0 (es) 1983-08-01
KR890001146B1 (ko) 1989-04-25
IT1150697B (it) 1986-12-17
FR2502149B1 (es) 1985-01-18
SE8201654L (sv) 1982-09-20
AU558451B2 (en) 1987-01-29
GB2095252B (en) 1985-04-17
BE892552A (fr) 1982-09-20
NZ200047A (en) 1985-07-12
IT8220259A0 (it) 1982-03-18
IE53076B1 (en) 1988-06-08
ES8501363A1 (es) 1984-12-01
IL65247A0 (en) 1982-05-31
IL65247A (en) 1987-07-31
PH18657A (en) 1985-08-29
DK120982A (da) 1982-09-20

Similar Documents

Publication Publication Date Title
EP0072352B1 (de) Benzazepin-2-one, Verfahren zu ihrer Herstellung, pharmazeutische Präparate die diese Verbindungen enthalten, sowie die Verbindungen zur therapeutischen Verwendung
US4128653A (en) Reduction of blood pressure with carboxyalkylacyl-pipecolic acid derivatives
KR890000662B1 (ko) 1-카복시 알카노일 인돌린-2-카복실산 유도체의 제조방법
EP0119954B1 (de) Gewisse 3-Amino-1-benzazepin-2-on-1-alkansäuren, Verfahren zu ihrer Herstellung, pharmazeutische Präparate enthaltend diese Verbindungen, sowie ihre therapeutische Verwendung
KR100504449B1 (ko) 세포 유착 억제제
EP0236872B1 (de) Hydroxylaminderivate, deren Herstellung und Verwendung für Heilmittel
EP0100200B1 (en) 2-substituted 4-amino-6,7-dimethoxyquinolines
US5576313A (en) Inhibitors of farnesyl-protein transferase
EP0119161B1 (de) Gewisse Benzazocinon- und Benzazoninon-Derivate, Verfahren zu ihrer Herstellung, pharmazeutische Präparate enthaltend diese Verbindungen, sowie ihre therapeutische Verwendung
CH658455A5 (de) Peptidderivate, verfahren zu deren herstellung und diese enthaltende arzneimittel.
JPH09500109A (ja) ファルネシル蛋白質トランスフェラーゼの阻害剤
DD201787A5 (de) Verfahren zur herstellung von substituierten acylderivaten von 1,2,3,4-tetrahydroisochinolin-3-carbonsaeuren
DD201782A5 (de) Verfahren zur herstellung von octahydro-1-(omega-mercaptoalkanoyl)-1h-indol 2-carbonsaeure-verbindungen
US4154937A (en) Hydroxycarbamoylalkylacylpipecolic acid compounds
DE4443390A1 (de) Neue dipeptidische p-Amidinobenzylamide mit N-terminalen Sulfonyl- bzw. Aminosulfonylresten
EP0847994B1 (de) Verfahren zur Herstellung gemischter Anhydride
EP0230242A2 (de) Substituierte 4-Amino-3-hydroxy-buttersäure-Derivate, Verfahren zu deren Herstellung, diese enthaltende Mittel und ihre Verwendung
EP0065301A1 (en) Isoquinoline carboxylic acid derivates, process for preparing and pharmaceutical composition containing the same
CZ322092A3 (en) N-(alpha-substituted pyridinyl)carbonyl dipeptides, process of their preparation and pharmaceutical compositions based thereon
EP0093805A1 (en) Octahydro-2-(omega-mercaptoalkanoyl)3-oxo-1H-isoindole-1-carboxylic acids and esters
EP0403828A1 (de) Renininhibitorische Peptide, Verfahren zur ihrer Herstellung und ihre Verwendung in Arzneimitteln
DE3507575A1 (de) Antihypertensive cyclische spiro-verbindungen, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische praeparate
US4503043A (en) Substituted acyl derivatives of octahydro-1H-isoindole-1-carboxylic acids
EP0059966B1 (en) Substituted thiazolidine carboxylic acid analogs and derivatives as antihypertensives
EP0187619A2 (de) 1,3-disubstituierte Tetrahydropyridine

Legal Events

Date Code Title Description
PL Patent ceased